Back to Results
First PageMeta Content



June 10, 2015 Pieris Pharmaceuticals Completes Dosing of Healthy Volunteers in Phase I Clinical Trial for Anticalin Program in Anemia PRS-080 Is Second Anticalin Successfully Administered to Humans
Add to Reading List

Document Date: 2015-06-10 08:00:36


Open Document

File Size: 39,33 KB

Share Result on Facebook
UPDATE